Call for a dedicated European legal framework for bacteriophage therapy.
about
Adapting Drug Approval Pathways for Bacteriophage-Based TherapeuticsPhage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting DiseasesTaking bacteriophage therapy seriously: a moral argumentPhage therapy--constraints and possibilities.Experimental phage therapy of burn wound infection: difficult first stepsThe search for therapeutic bacteriophages uncovers one new subfamily and two new genera of Pseudomonas-infecting Myoviridae.Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy.Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria.Bacteriophage therapy: a regulatory perspective.Genetically modified bacteriophages in applied microbiology.Long-term effects of single and combined introductions of antibiotics and bacteriophages on populations of Pseudomonas aeruginosa.Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework.Unexploited opportunities for phage therapy."French Phage Network"-Second Meeting ReportRegulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines.Guidelines for Bacteriophage Product Certification.Bacteriophage Production in Compliance with Regulatory Requirements.Guidelines to Compose an Ideal Bacteriophage Cocktail.Criteria for Selecting Suitable Infectious Diseases for Phage Therapy.Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
P2860
Q26740597-0D31EC38-FCF8-407C-B1A1-F73EA7C81CB0Q28069939-512874BF-F125-45B1-B9B4-3D9E8922918CQ33608714-9228C41C-6631-4F0F-93A0-D690CA0E9C30Q33667556-BC5E52D6-9650-4325-A6EA-D782ED43A919Q34420348-0DBBE3C4-00DD-43C8-8F70-108C2641AE06Q35023371-1F2F5010-D750-494D-B8AB-BADBD9E8F86BQ35575223-2FFE2878-B8F0-4E02-AB70-76ACCC134245Q38537430-B3541A52-B28D-4EBC-B402-3D96B2B14E6DQ38805538-0F9D04AA-6DAE-4059-95DB-7E01FE9417F9Q38870317-71C93208-D578-4746-9AE6-AC0517DE4EBBQ40165457-3186CCF0-6308-48C1-AE3D-AA68B270F2AFQ40867366-2D79D317-31AF-48D4-973C-6FD923468F44Q40964122-612D1AB5-B2AB-4FAE-B0E8-C05A39E1916BQ42357412-C23CFD78-FFB6-457F-99B5-9C34C6C121F6Q48511190-15F8A8CC-E69B-4FE9-8254-30C0C7AE1332Q48606487-44352462-BEB2-4E9A-A3D8-F62ED5D20B6BQ50100571-067FDD96-1025-47F8-9DA4-F9D517D787EDQ50100609-12295A88-5851-43EE-9533-3B47CD249CB6Q53075476-824B60A8-392B-42AD-9890-7BC1F52B2D85Q58571995-FAAC53C0-0719-4DDC-B6F0-8BFC755A0D5E
P2860
Call for a dedicated European legal framework for bacteriophage therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Call for a dedicated European legal framework for bacteriophage therapy.
@en
Call for a dedicated European legal framework for bacteriophage therapy.
@nl
type
label
Call for a dedicated European legal framework for bacteriophage therapy.
@en
Call for a dedicated European legal framework for bacteriophage therapy.
@nl
prefLabel
Call for a dedicated European legal framework for bacteriophage therapy.
@en
Call for a dedicated European legal framework for bacteriophage therapy.
@nl
P2093
P2860
P50
P921
P1476
Call for a dedicated European legal framework for bacteriophage therapy
@en
P2093
Daniel De Vos
Gilbert Verbeken
Serge Jennes
P2860
P2888
P304
P356
10.1007/S00005-014-0269-Y
P577
2014-02-06T00:00:00Z